Abstract
The polysaccharide alginate is a linear chain binary copolymer made of guluronic acid and mannuronic acid subunits. Alginate is a natural polymer material produced by a number of organisms, including brown algae and bacteria. It has found application in a variety of areas, including food, cosmetics, pharmaceutical and biomedical industries. In recent years, a number of studies have been published on covalent modification of alginate, often through carbodiimide-mediated reactions at the carboxyl moieties. These modifications have imparted a wide range of different chemical and physical material properties, including altered reactivity, hydrophilicity, viscosity and sorption characteristics. This mini-review focuses on the methods and applications of organically modified alginates from recent publications.
Keywords: Alginate, modification, biopolymer, polysaccharide
Mini-Reviews in Organic Chemistry
Title: Organic Modification of the Polysaccharide Alginate
Volume: 7 Issue: 1
Author(s): Matthew D. Cathell, Janah C. Szewczyk and Caroline L. Schauer
Affiliation:
Keywords: Alginate, modification, biopolymer, polysaccharide
Abstract: The polysaccharide alginate is a linear chain binary copolymer made of guluronic acid and mannuronic acid subunits. Alginate is a natural polymer material produced by a number of organisms, including brown algae and bacteria. It has found application in a variety of areas, including food, cosmetics, pharmaceutical and biomedical industries. In recent years, a number of studies have been published on covalent modification of alginate, often through carbodiimide-mediated reactions at the carboxyl moieties. These modifications have imparted a wide range of different chemical and physical material properties, including altered reactivity, hydrophilicity, viscosity and sorption characteristics. This mini-review focuses on the methods and applications of organically modified alginates from recent publications.
Export Options
About this article
Cite this article as:
Cathell D. Matthew, Szewczyk C. Janah and Schauer L. Caroline, Organic Modification of the Polysaccharide Alginate, Mini-Reviews in Organic Chemistry 2010; 7 (1) . https://dx.doi.org/10.2174/1570193X11007010061
DOI https://dx.doi.org/10.2174/1570193X11007010061 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biology of Protooncogene c-kit Receptor and Spermatogenesis
Current Pharmacogenomics Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Clarifying Prion Protein Functions Using Knockout Mice and Derived Cell Lines
Mini-Reviews in Medicinal Chemistry The Role of JNK Signalling in Responses to Oxidative DNA Damage
Current Drug Targets A Medicinal Mushroom: Phellinus Linteus
Current Medicinal Chemistry 5-ht6 Receptors
Current Drug Targets - CNS & Neurological Disorders Ganglioside GM3 and Its Role in Cancer
Current Medicinal Chemistry Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
Current Drug Targets Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
Current Cancer Drug Targets Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets MAPKs and Their Inhibitors in Neuronal Differentiation
Current Enzyme Inhibition Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design The Development of Preventives and Therapeutics for Alzheimers Disease that Inhibit the Formation of β-Amyloid Fibrils (fAβ), as Well as Destabilize Preformed fAβ
Current Pharmaceutical Design A Quantitative Proteomic Analysis to Reveal Effects of N-acetylcysteine on H<sub>2</sub>O<sub>2</sub>-induced Cytotoxicity
Current Proteomics